HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies

Broadly neutralizing antibody (bnAb) induction is a high priority for effective HIV-1 vaccination. VRC01-class bnAbs that target the CD4 binding site (CD4bs) of trimeric HIV-1 envelope (Env) glycoprotein spikes are particularly attractive to elicit because of their extraordinary breadth and potency...

Full description

Bibliographic Details
Main Authors: Labranche, CC, McGuire, AT, Gray, MD, Behrens, S, Zhou, T, Sattentau, QJ, Peacock, J, Eaton, A, Greene, K, Gao, H, Tang, H, Perez, LG, Saunders, KO, Mascola, JR, Haynes, BF, Stamatatos, L, Montefiori, DC
Format: Journal article
Language:English
Published: Public Library of Science 2018
_version_ 1797076421939560448
author Labranche, CC
McGuire, AT
Gray, MD
Behrens, S
Zhou, T
Sattentau, QJ
Peacock, J
Eaton, A
Greene, K
Gao, H
Tang, H
Perez, LG
Saunders, KO
Mascola, JR
Haynes, BF
Stamatatos, L
Montefiori, DC
author_facet Labranche, CC
McGuire, AT
Gray, MD
Behrens, S
Zhou, T
Sattentau, QJ
Peacock, J
Eaton, A
Greene, K
Gao, H
Tang, H
Perez, LG
Saunders, KO
Mascola, JR
Haynes, BF
Stamatatos, L
Montefiori, DC
author_sort Labranche, CC
collection OXFORD
description Broadly neutralizing antibody (bnAb) induction is a high priority for effective HIV-1 vaccination. VRC01-class bnAbs that target the CD4 binding site (CD4bs) of trimeric HIV-1 envelope (Env) glycoprotein spikes are particularly attractive to elicit because of their extraordinary breadth and potency of neutralization in vitro and their ability to protect against infection in animal models. Glycans bordering the CD4bs impede the binding of germline-reverted forms of VRC01-class bnAbs and therefore constitute a barrier to early events in initiating the correct antibody lineages. Deleting a subset of these glycans permits Env antigen binding but not virus neutralization, suggesting that additional barriers impede germline-reverted VRC01-class antibody binding to functional Env trimers. We investigated the requirements for functional Env trimer engagement of VRC01-class naïve B cell receptors by using virus neutralization and germline-reverted antibodies as surrogates for the interaction. Targeted deletion of a subset of N-glycans bordering the CD4bs, combined with Man5 enrichment of remaining N-linked glycans that are otherwise processed into larger complex-type glycans, rendered HIV-1 426c Env-pseudotyped virus (subtype C, transmitted/founder) highly susceptible to neutralization by near germline forms of VRC01-class bnAbs. Neither glycan modification alone rendered the virus susceptible to neutralization. The potency of neutralization in some cases rivaled the potency of mature VRC01 against wildtype viruses. Neutralization by the germline-reverted antibodies was abrogated by the known VRC01 resistance mutation, D279K. These findings improve our understanding of the restrictions imposed by glycans in eliciting VRC01-class bnAbs and enable a neutralization-based strategy to monitor vaccine-elicited early precursors of this class of bnAbs.
first_indexed 2024-03-07T00:03:31Z
format Journal article
id oxford-uuid:76c6ef32-6f0d-48ae-b1eb-ca6e7bb4d91a
institution University of Oxford
language English
last_indexed 2024-03-07T00:03:31Z
publishDate 2018
publisher Public Library of Science
record_format dspace
spelling oxford-uuid:76c6ef32-6f0d-48ae-b1eb-ca6e7bb4d91a2022-03-26T20:18:35ZHIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodiesJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:76c6ef32-6f0d-48ae-b1eb-ca6e7bb4d91aEnglishSymplectic Elements at OxfordPublic Library of Science2018Labranche, CCMcGuire, ATGray, MDBehrens, SZhou, TSattentau, QJPeacock, JEaton, AGreene, KGao, HTang, HPerez, LGSaunders, KOMascola, JRHaynes, BFStamatatos, LMontefiori, DCBroadly neutralizing antibody (bnAb) induction is a high priority for effective HIV-1 vaccination. VRC01-class bnAbs that target the CD4 binding site (CD4bs) of trimeric HIV-1 envelope (Env) glycoprotein spikes are particularly attractive to elicit because of their extraordinary breadth and potency of neutralization in vitro and their ability to protect against infection in animal models. Glycans bordering the CD4bs impede the binding of germline-reverted forms of VRC01-class bnAbs and therefore constitute a barrier to early events in initiating the correct antibody lineages. Deleting a subset of these glycans permits Env antigen binding but not virus neutralization, suggesting that additional barriers impede germline-reverted VRC01-class antibody binding to functional Env trimers. We investigated the requirements for functional Env trimer engagement of VRC01-class naïve B cell receptors by using virus neutralization and germline-reverted antibodies as surrogates for the interaction. Targeted deletion of a subset of N-glycans bordering the CD4bs, combined with Man5 enrichment of remaining N-linked glycans that are otherwise processed into larger complex-type glycans, rendered HIV-1 426c Env-pseudotyped virus (subtype C, transmitted/founder) highly susceptible to neutralization by near germline forms of VRC01-class bnAbs. Neither glycan modification alone rendered the virus susceptible to neutralization. The potency of neutralization in some cases rivaled the potency of mature VRC01 against wildtype viruses. Neutralization by the germline-reverted antibodies was abrogated by the known VRC01 resistance mutation, D279K. These findings improve our understanding of the restrictions imposed by glycans in eliciting VRC01-class bnAbs and enable a neutralization-based strategy to monitor vaccine-elicited early precursors of this class of bnAbs.
spellingShingle Labranche, CC
McGuire, AT
Gray, MD
Behrens, S
Zhou, T
Sattentau, QJ
Peacock, J
Eaton, A
Greene, K
Gao, H
Tang, H
Perez, LG
Saunders, KO
Mascola, JR
Haynes, BF
Stamatatos, L
Montefiori, DC
HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies
title HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies
title_full HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies
title_fullStr HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies
title_full_unstemmed HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies
title_short HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies
title_sort hiv 1 envelope glycan modifications that permit neutralization by germline reverted vrc01 class broadly neutralizing antibodies
work_keys_str_mv AT labranchecc hiv1envelopeglycanmodificationsthatpermitneutralizationbygermlinerevertedvrc01classbroadlyneutralizingantibodies
AT mcguireat hiv1envelopeglycanmodificationsthatpermitneutralizationbygermlinerevertedvrc01classbroadlyneutralizingantibodies
AT graymd hiv1envelopeglycanmodificationsthatpermitneutralizationbygermlinerevertedvrc01classbroadlyneutralizingantibodies
AT behrenss hiv1envelopeglycanmodificationsthatpermitneutralizationbygermlinerevertedvrc01classbroadlyneutralizingantibodies
AT zhout hiv1envelopeglycanmodificationsthatpermitneutralizationbygermlinerevertedvrc01classbroadlyneutralizingantibodies
AT sattentauqj hiv1envelopeglycanmodificationsthatpermitneutralizationbygermlinerevertedvrc01classbroadlyneutralizingantibodies
AT peacockj hiv1envelopeglycanmodificationsthatpermitneutralizationbygermlinerevertedvrc01classbroadlyneutralizingantibodies
AT eatona hiv1envelopeglycanmodificationsthatpermitneutralizationbygermlinerevertedvrc01classbroadlyneutralizingantibodies
AT greenek hiv1envelopeglycanmodificationsthatpermitneutralizationbygermlinerevertedvrc01classbroadlyneutralizingantibodies
AT gaoh hiv1envelopeglycanmodificationsthatpermitneutralizationbygermlinerevertedvrc01classbroadlyneutralizingantibodies
AT tangh hiv1envelopeglycanmodificationsthatpermitneutralizationbygermlinerevertedvrc01classbroadlyneutralizingantibodies
AT perezlg hiv1envelopeglycanmodificationsthatpermitneutralizationbygermlinerevertedvrc01classbroadlyneutralizingantibodies
AT saundersko hiv1envelopeglycanmodificationsthatpermitneutralizationbygermlinerevertedvrc01classbroadlyneutralizingantibodies
AT mascolajr hiv1envelopeglycanmodificationsthatpermitneutralizationbygermlinerevertedvrc01classbroadlyneutralizingantibodies
AT haynesbf hiv1envelopeglycanmodificationsthatpermitneutralizationbygermlinerevertedvrc01classbroadlyneutralizingantibodies
AT stamatatosl hiv1envelopeglycanmodificationsthatpermitneutralizationbygermlinerevertedvrc01classbroadlyneutralizingantibodies
AT montefioridc hiv1envelopeglycanmodificationsthatpermitneutralizationbygermlinerevertedvrc01classbroadlyneutralizingantibodies